These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2091976)

  • 1. [Use of salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis in bullous diseases].
    Cappio F; Colombo MD; Caputo R
    G Ital Dermatol Venereol; 1990 Dec; 125(12):LXI-LXIV. PubMed ID: 2091976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.
    Montemurro L; Schiraldi G; Fraioli P; Tosi G; Riboldi A; Rizzato G
    Calcif Tissue Int; 1991 Aug; 49(2):71-6. PubMed ID: 1913297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of corticosteroid bone loss.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    Osteoporos Int; 1993; 3 Suppl 1():141-3. PubMed ID: 8461542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of ovariectomized patients with intramuscular and nasal-spray synthetic calcitonin].
    Zara C; Perotti F; Ferraro R; Lauri A; Saviotti C; Montrasio MG; Caprotti M; Polatti F
    Minerva Endocrinol; 1989; 14(1):53-6. PubMed ID: 2733647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
    J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intranasal salmon calcitonin for the prophylaxis of bone mineral loss in steroid-treated chronic obstructive lung diseases ].
    Böhning W; Ringe JD; Welzel D; Bode V
    Arzneimittelforschung; 1990 Sep; 40(9):1000-3. PubMed ID: 2080934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
    Overgaard K; Ravn P; Hansen MA; Christiansen C
    Ugeskr Laeger; 1993 Aug; 155(31):2387-91. PubMed ID: 8346588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Salmon calcitonin in the treatment of osteoporosis].
    Payer J; Killinger Z; Ondrejka P
    Vnitr Lek; 1999 Aug; 45(8):476-9. PubMed ID: 11045148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis.
    Nishioka T; Kurayama H; Yasuda T; Udagawa J; Matsumura C; Niimi H
    J Pediatr; 1991 May; 118(5):703-7. PubMed ID: 2019923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
    Buckley LM; Marquez M; Feezor R; Ruffin DM; Benson LL
    Arthritis Rheum; 1999 Aug; 42(8):1736-9. PubMed ID: 10446875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.
    Reginster JY; Denis D; Albert A; Deroisy R; Lecart MP; Fontaine MA; Lambelin P; Franchimont P
    Lancet; 1987 Dec; 2(8574):1481-3. PubMed ID: 2892047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis.
    Gennari C
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():61-5. PubMed ID: 2667872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin and postmenopausal bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Fontaine MA; Albert A; Franchimont P
    Exp Gerontol; 1990; 25(3-4):349-56. PubMed ID: 2226670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nasal salmon calcitonin on calcium and bone metabolism.
    Thamsborg G
    Dan Med Bull; 1999 Apr; 46(2):118-26. PubMed ID: 10327295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid-induced bone loss. Prevention and management.
    Picado C; Luengo M
    Drug Saf; 1996 Nov; 15(5):347-59. PubMed ID: 8941496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.